STERIS STE
STERIS is a medical technology company that designs, manufactures, and sells sterilization, disinfection, and surgical health solutions for hospitals, pharmaceuticals, and laboratories. STERIS maintains solid financial health (debt/EBITDA 0.95x) and stable double-digit earnings growth, although its valuation is not particularly cheap (P/E 25.5) and momentum is weak (score 4.17).
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
STERIS is a medical technology company that designs, manufactures, and sells sterilization, disinfection, and surgical health solutions for hospitals, pharmaceuticals, and laboratories. STERIS maintains solid financial health (debt/EBITDA 0.95x) and stable double-digit earnings growth, although its valuation is not particularly cheap (P/E 25.5) and momentum is weak (score 4.17).
Score by category
| Category | Score |
|---|---|
| Financial health | 7.5 |
| Quality / Moat | 5.9 |
| Valuation | 5.3 |
| Growth | 6.5 |
| Dividend | 5.7 |
| Momentum | 4.2 |
| Risk & Context | 6.8 |
OVERALL SCORE: 6.1/10
Context and risks
No material exposure to current macro factors. The sterilization and medical devices business does not depend on oil, 10-year Treasury yields, or the specific geopolitical tensions mentioned.
News considered in the analysis
- 3 Healthcare Stocks That Fall Short — Listado genérico sin información específica sobre STERIS.
- 3 Mid-Cap Stocks with Open Questions — Listado genérico sin información específica sobre STERIS.
- 1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Brush Off — Listado genérico sin información específica sobre STERIS.
- STERIS Stock: Is STE Underperforming the Healthcare Sector? — Análisis de rendimiento relativo sin información nueva.
- Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound? — La caída post-resultados ya está descontada en el precio y refleja el momentum negativo actual.
Verdict: Hold positions; business quality justifies the premium, but the price offers no margin of safety.
Main risk: The main risk is a slowdown in demand for sterilization equipment and consumables if hospitals cut capital spending, which could impact revenue growth.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →